6NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials[J]. J Clin Oncol, 2008,26(28 ) :4617 -4625.
7Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004 [J]. CA Cancer J Clin, 2004,54:8 -29.
8Therasse P, Arbuck SG. New guidelines to evaluate the response to treatment in solid tumors [ J ]. Nat Cancer Inst, 2000, 92 (3) : 205 - 216.
9Goldie JH, Coldman AJ. A mathematical model for relating the drug sensitivity of tunlors to their spontaneous mutation rate[ J ]. Cancer Treat Rep, 1979,63 (11-12) : 1727 - 1733.
10Fathi AT, Brahmer JR. Chemotherapy for advanced stage non-small cell lung cancer [ J ]. Semin Thorac Cardiovasc Surg, 2008,20(3) :210 -216
3Lew DT,Blachman K,Zaloshnja E.Chapter 10:a macromodel of smoking and lung cancer,examining aggregate trends in lung cancer rates using the CPS-Ⅰand CPS-Ⅱand two-stage clonal expansion models[J].Risk Anal,2012,32(Suppl 1):125.
4Zhou J,Zhao WY,Ma X,et al.The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626.
5Liu X,Li Y,Zeng F,et al.Chanyubaoyuantang,the water extract of a Chinese medicine prescription,induces s-phase arrest and mitochondria-mediated apoptosis in human lung adenocarcinoma cells[J].Integr Cancer Ther,2011,11(4):337.
6Okuda K,Hirose T,Oki Y,et al.Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease[J].Anticancer Res,2012,32(12):5 475.
7Kong C,Guo WJ,Zha WW,et al.A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer:analysis of data from the literature[J].Lung Cancer,2014,84(1):7.
